spacer
spacer

PDBsum entry 1af3

Go to PDB code: 
protein links
Regulatory protein PDB id
1af3

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
145 a.a. *
Waters ×51
* Residue conservation analysis
PDB id:
1af3
Name: Regulatory protein
Title: Rat bcl-xl an apoptosis inhibitory protein
Structure: Apoptosis regulator bcl-x. Chain: a. Fragment: soluble region. Engineered: yes
Source: Rattus norvegicus. Norway rat. Organism_taxid: 10116. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
2.50Å     R-factor:   0.225     R-free:   0.273
Authors: M.Aritomi,N.Kunishima,N.Inohara,Y.Ishibashi,S.Ohta,K.Morikawa
Key ref:
M.Aritomi et al. (1997). Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family. J Biol Chem, 272, 27886-27892. PubMed id: 9346936 DOI: 10.1074/jbc.272.44.27886
Date:
21-Mar-97     Release date:   07-Jul-97    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P53563  (B2CL1_RAT) -  Bcl-2-like protein 1 from Rattus norvegicus
Seq:
Struc:
233 a.a.
145 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.?
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

 

 
DOI no: 10.1074/jbc.272.44.27886 J Biol Chem 272:27886-27892 (1997)
PubMed id: 9346936  
 
 
Crystal structure of rat Bcl-xL. Implications for the function of the Bcl-2 protein family.
M.Aritomi, N.Kunishima, N.Inohara, Y.Ishibashi, S.Ohta, K.Morikawa.
 
  ABSTRACT  
 
Bcl-xL is a member of the Bcl-2 protein family, which regulates apoptosis. Preparation of recombinant rat Bcl-xL yielded two forms, one deamidated at -Asn-Gly- sequences to produce isoaspartates and the other not deamidated. The crystal structures of the two forms show that they both adopt an essentially identical backbone structure which resembles the fold of human Bcl-xL: three layers of two alpha-helices each, capped at one end by two short helices. Both forms have a long disordered region, which contains the potential deamidation sites. The molecular structure exhibits a low level of interhelical interactions, the presence of three cavities, and a notable hydrophobic cleft surrounded by walls rich in basic residues. These unique structural features may be favorable for its accommodation into membranes or for possible rearrangement to modulate homo-/heterodimerization. Homology modeling of Bcl-2 and Bax, based on the Bcl-xL structure, suggests that Bax has the strongest potential for membrane insertion. Furthermore, we found a possible interface for interaction with non-Bcl-2 family member proteins, such as CED-4 homologues.
 
  Selected figure(s)  
 
Figure 3.
Fig. 3. Stereoview of the three cavities and the -carbon backbone. Cavities were calculated by the GRASP (42) program. The^ view is from the bottom looking into helices 5 and 6. Cavity A is formed by Phe^12, Leu90, Ala^93, Gly94, Phe^97, Trp137, Ile^140, Val141, Ala^142, Phe^144, Ser145, Trp181, Ile^182, Trp188, Phe^191, and Tyr195; cavity B by Phe^12, Leu13, Lys16, Leu17, Lys20, Tyr22, Gly148, Cys151, and Val152; and cavity C by Leu112, Ile^114, Thr115, Pro116, Gly117, Thr118, Phe^123, Leu150, Ser154, Leu162, Arg165, Ile^166, and Trp169. Cavities A and B are partitioned by the side chain of Phe^12.
Figure 4.
Fig. 4. Stereo pairs showing the hydrophobic clefts in the bottom region for Bcl-x[L](B) (a) and for a Bax model (b). The hydrophobicity was mapped onto the solvent accessible surface using the GRASP (42) program, with the hydropathy values (44). The molecules are viewed in the same direction as in Fig. 3. The blue color represents hydrophilic regions and the yellow represents hydrophobic^ regions. The two red lines in a indicate the hydrogen-bonds: Tyr22-Asp156 and Arg165-Pro116. The three-dimensional structure of Bax was constructed by homology modeling based on that of Bcl-x[L](B) and by using a previously reported sequence alignment (29).
 
  The above figures are reprinted by permission from the ASBMB: J Biol Chem (1997, 272, 27886-27892) copyright 1997.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
20480043 G.J.Rautureau, C.L.Day, and M.G.Hinds (2010).
Intrinsically disordered proteins in bcl-2 regulated apoptosis.
  Int J Mol Sci, 11, 1808-1824.  
20606265 S.Noguchi (2010).
Isomerization mechanism of aspartate to isoaspartate implied by structures of Ustilago sphaerogena ribonuclease U2 complexed with adenosine 3'-monophosphate.
  Acta Crystallogr D Biol Crystallogr, 66, 843-849.
PDB codes: 3agn 3ago
19328553 K.R.Rockwell, and B.T.Huber (2009).
Biologically distinct conformations of Bcl-x can be resolved using 2D isoelectric focusing.
  Mol Immunol, 46, 1605-1612.  
19340835 Y.Zhan, G.Jia, D.Wu, Y.Xu, and L.Xu (2009).
Design and synthesis of a gossypol derivative with improved antitumor activities.
  Arch Pharm (Weinheim), 342, 223-229.  
18275607 A.A.Arnold, A.Aboukameel, J.Chen, D.Yang, S.Wang, A.Al-Katib, and R.M.Mohammad (2008).
Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model.
  Mol Cancer, 7, 20.  
18248095 B.Ku, J.S.Woo, C.Liang, K.H.Lee, H.S.Hong, X.E, K.S.Kim, J.U.Jung, and B.H.Oh (2008).
Structural and biochemical bases for the inhibition of autophagy and apoptosis by viral BCL-2 of murine gamma-herpesvirus 68.
  PLoS Pathog, 4, e25.
PDB codes: 2bzw 3bl2
18827561 J.Sun, Z.M.Li, Z.Y.Hu, X.B.Lin, N.N.Zhou, L.J.Xian, D.J.Yang, and W.Q.Jiang (2008).
ApoG2 inhibits antiapoptotic Bcl-2 family proteins and induces mitochondria-dependent apoptosis in human lymphoma U937 cells.
  Anticancer Drugs, 19, 967-974.  
18093693 S.Asoh, and S.Ohta (2008).
PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymes.
  Adv Drug Deliv Rev, 60, 499-516.  
17416629 A.J.García-Sáez, S.Chiantia, J.Salgado, and P.Schwille (2007).
Pore formation by a Bax-derived peptide: effect on the line tension of the membrane probed by AFM.
  Biophys J, 93, 103-112.  
17177603 R.Zhao, D.Oxley, T.S.Smith, G.A.Follows, A.R.Green, and D.R.Alexander (2007).
DNA damage-induced Bcl-xL deamidation is mediated by NHE-1 antiport regulated intracellular pH.
  PLoS Biol, 5, e1.  
16632808 C.Wang, D.A.Neff, J.G.Krolikowski, D.Weihrauch, M.Bienengraeber, D.C.Warltier, J.R.Kersten, and P.S.Pagel (2006).
The influence of B-cell lymphoma 2 protein, an antiapoptotic regulator of mitochondrial permeability transition, on isoflurane-induced and ischemic postconditioning in rabbits.
  Anesth Analg, 102, 1355-1360.  
16951924 O.Kutuk, and H.Basaga (2006).
Bcl-2 protein family: implications in vascular apoptosis and atherosclerosis.
  Apoptosis, 11, 1661-1675.  
15182852 D.A.Hildeman (2004).
Regulation of T-cell apoptosis by reactive oxygen species.
  Free Radic Biol Med, 36, 1496-1504.  
14749125 R.Zhao, F.T.Yang, and D.R.Alexander (2004).
An oncogenic tyrosine kinase inhibits DNA repair and DNA-damage-induced Bcl-xL deamidation in T cell transformation.
  Cancer Cell, 5, 37-49.  
12576135 A.Clerk, S.M.Cole, T.E.Cullingford, J.G.Harrison, M.Jormakka, and D.M.Valks (2003).
Regulation of cardiac myocyte cell death.
  Pharmacol Ther, 97, 223-261.  
12660157 M.G.Hinds, M.Lackmann, G.L.Skea, P.J.Harrison, D.C.Huang, and C.L.Day (2003).
The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity.
  EMBO J, 22, 1497-1507.
PDB code: 1o0l
12372300 B.E.Deverman, B.L.Cook, S.R.Manson, R.A.Niederhoff, E.M.Langer, I.Rosová, L.A.Kulans, X.Fu, J.S.Weinberg, J.W.Heinecke, K.A.Roth, and S.J.Weintraub (2002).
Bcl-xL deamidation is a critical switch in the regulation of the response to DNA damage.
  Cell, 111, 51-62.  
12475933 S.Asoh, I.Ohsawa, T.Mori, K.Katsura, T.Hiraide, Y.Katayama, M.Kimura, D.Ozaki, K.Yamagata, and S.Ohta (2002).
Protection against ischemic brain injury by protein therapeutics.
  Proc Natl Acad Sci U S A, 99, 17107-17112.  
12401491 Z.Huang (2002).
The chemical biology of apoptosis. Exploring protein-protein interactions and the life and death of cells with small molecules.
  Chem Biol, 9, 1059-1072.  
11828422 U.Sartorius, I.Schmitz, and P.H.Krammer (2001).
Molecular mechanisms of death-receptor-mediated apoptosis.
  Chembiochem, 2, 20-29.  
11137452 I.Schmitz, S.Kirchhoff, and P.H.Krammer (2000).
Regulation of death receptor-mediated apoptosis pathways.
  Int J Biochem Cell Biol, 32, 1123-1136.  
10869179 M.del Mar Martínez-Senac, S.Corbalán-García, and J.C.Gómez-Fernández (2000).
Study of the secondary structure of the C-terminal domain of the antiapoptotic protein bcl-2 and its interaction with model membranes.
  Biochemistry, 39, 7744-7752.  
10759888 R.Nanbu-Wakao, S.Asoh, K.Nishimaki, R.Tanaka, and S.Ohta (2000).
Bacterial cell death induced by human pro-apoptotic Bax is blocked by an RNase E mutant that functions in an anti-oxidant pathway.
  Genes Cells, 5, 155-167.  
10747022 S.Conus, T.Kaufmann, I.Fellay, I.Otter, T.Rossé, and C.Borner (2000).
Bcl-2 is a monomeric protein: prevention of homodimerization by structural constraints.
  EMBO J, 19, 1534-1544.  
10494853 H.Bruhn, and M.Leippe (1999).
Comparative modeling of amoebapores and granulysin based on the NK-lysin structure-structural and functional implications.
  Biol Chem, 380, 1001-1007.  
10101960 R.A.Kinloch, J.M.Treherne, L.M.Furness, and I.Hajimohamadreza (1999).
The pharmacology of apoptosis.
  Trends Pharmacol Sci, 20, 35-42.  
10085289 S.Desagher, A.Osen-Sand, A.Nichols, R.Eskes, S.Montessuit, S.Lauper, K.Maundrell, B.Antonsson, and J.C.Martinou (1999).
Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis.
  J Cell Biol, 144, 891-901.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.

 

spacer

spacer